Dr. Aubrey de Grey is an aging researcher and the world’s leading proponent of the provocative view that medical technology will one day enable people to control the aging process. He questions the fundamental assumption that ageing is invincible.

Dr. de Grey is a biomedical gerontologist, developed the SENS platform and founded the SENS Research Foundation to implement it. SENS is a California-based biomedical research organization whose research is dedicated to combating the aging process. Aubrey de Grey is Vice President of AgeX Therapeutics, which focuses on the development and commercialization of novel therapeutics for human aging.

Dr. de Grey has a BA in Computer Science and his Ph. in Biology from the University of Cambridge, UK. He is Editor-in-Chief of Rejuvenation Research, the world’s premier journal on prevention of aging, a Fellow of the Gerontological Society of America and the American Aging Association, and serves on the editorial and scientific advisory boards of numerous journals and organizations.